Synergy says Q1 growth limited by currency translation
Synergy Health, a provider of outsourced sterilisation services, disappointed investors by admitting headline growth in the first quarter had been held back by currency translation with the devaluation of the euro.
Synergy Health, a provider of outsourced sterilisation services, disappointed investors by admitting headline growth in the first quarter had been held back by currency translation with the devaluation of the euro.
It was by no means all bad news, however, with improved margins offsetting the impact of slower reported revenue growth.
Reported revenue increased by 3.5% to £79.3m compared to the same period last year (2011: £76.6m), whilst adjusted operating margins improved by 220 basis points to 16.7% (2011: 14.4%).
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Underlying sales grew in all regions, up 3.0% in the UK and Ireland, 5.5% in Europe and the Middle East, 32.9% in Asia and Africa, and 32.4% in the Americas.
The UK and Ireland were affected by extended public holidays, although revenue for Applied Sterilisation Technologies (AST) showed good growth of 7.4% with particularly strong growth in Ireland.
Europe and the Middle East improved slightly on the last quarter with AST growth partially mitigated by continued price competition in the Dutch linen market.
A strong performance in Asia and Africa was seen as the firm continues to progress a number of opportunities and expects to reach financial close within the next few months with associated revenue commencing in 2013/14.
In the Americas the new plant in Florida is now processing product and will double in capacity towards the end of the summer, the firm said.
Net debt at July 1st had decreased to £167.7m from £173.5m at April 1st. Following the acquisition of SRI, net debt has since increased to £191m, corresponding to a net debt to EBITDA ratio of around 2.0 times, comfortably within its banking covenant of 3.25 times.
The share price fell 3.26% to 918.50p by 11:19.
NR
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
-
Associated British Foods is an overlooked gem going cheap — should you buy shares?
Associated British Foods, the owner of Primark, is a family-owned business, which means it is passed over by the increasingly popular passive investment funds. That spells opportunity for private investors, says Jamie Ward.
By Jamie Ward Published
-
8 of the best houses for sale for around £1 million
This week: the best houses for sale for around £1 million – from a wing of a Grade II-listed Victorian manor house in Sunderland, to a brick-and-flint cottage in Cley next the Sea, Norfolk
By Natasha Langan Published